ask="0.6500"
ask_size="600"
average_daily_volume="474483"
bid="0.6217"
bid_size="5000"
book_value="1.6420"
change="-0.0105"
change_from_200_day_moving_average="-0.4573"
change_from_50_day_moving_average="-0.0587"
change_from_52_week_high="-2.7499"
change_From_52_week_low="0.1201"
change_in_percent="-1.5895%"
close="0.6501"
dividend_pay_date="8/19/2015"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-1.5860"
ebitda="-16.45M"
eps_estimate_current_year="-1.5200"
eps_estimate_next_quarter="-0.4100"
eps_estimate_next_year="-1.2400"
ex_dividend_date="8/20/2015"
float_shares="5445000"
high="0.6800"
high_52_weeks="3.4000"
last_trade_date="12/30/2016"
last_trade_price="0.6501"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.6410"
low_52_weeks="0.5300"
market_capitalization="7.82M"
moving_average_200_day="1.1074"
moving_average_50_day="0.7088"
name="Catalyst Biosciences
Inc."
notes="N/A"
one_year_target_price="3.2500"
open="0.6698"
pe_ratio="N/A"
peg_ratio="0.0200"
percent_change_from_200_day_moving_average="-41.2928%"
percent_change_from_50_day_moving_average="-8.2847%"
percent_change_from_52_week_high="-80.8794%"
percent_change_from_52_week_low="+22.6604%"
previous_close="0.6606"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.4023"
price_per_sales="18.1793"
revenue="437000.00"
shares_outstanding="12026000"
short_ratio="0.0900"
stock_exchange="NCM"
symbol="CBIO"
volume="164001"
weeks_range_52="0.5300 - 3.4000"
